0
BioSpecifics Technologies Corp. Banner Image

BioSpecifics Technologies Corp.

  • Ticker BSTC
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
BioSpecifics Technologies Corp. Logo Image
  • 1-10 Employees
  • Based in Lynbrook, New York
BioSpecifics Technologies Corp., a biopharmaceutical company, engages in the development of an injectable collagenase clostridium histolyticum for multiple indications in the United States. The company offers injectable collagenase for the treatment of Dupuytren’s contracture and Peyronie’s disease under the XIAFLEX brand in Canada, Australia, Brazil, and Mexico, as well as under XIAPEXMore brand name in Europe.
BioSpecifics Technologies Corp.

Most Recent Annual Report

BioSpecifics Technologies Corp. MOST RECENT 2019 Annual Report and Form 10K

BioSpecifics Technologies Corp. does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports